Search Results 1451-1460 of 16794 for monoclonal antibody

1. Autoimmune epilepsy - Doctors and departments - Mayo Clinic

   lycoprotein antibody-associated disease, Neuropathy, Paraneoplastic syndromes of the nervous system, Myasthenia gravis, Myositis, Autoimmune epilepsy. Show ...

2. What are the new types of tests for COVID-19? - Mayo Clinic News Network

   Binnicker goes on to discuss blood tests that determine if you had COVID-19. A blood test for antibodies is used to determine how many people in a population ...

3. A Study to Determine Late Outcomes and Immunological Responses in Children With/Without Multisystem Inflammatory Syndrome After SARS-CoV-2 - Mayo Clinic

   ... antibody testing, may be enrolled as participants. If subsequent antibody testing is positive, cases will be labelled as confirmed MIS-C. If SARS-CoV-2 antibody ...

4. Chikungunya vaccine, recombinant (intramuscular route) - Mayo Clinic

   The vaccine works by causing your body to produce its own protection (antibodies) against the disease. This vaccine is to be given only by or under the ...

5. A Phase III, Safety, Tolerability and Efficacy of Combination Treatment of BL-8040 and G-GSF as Compared to Placebo and G-CSF for thE MobilizatioN of HematopoiEtic Stem Cells for Autologous TransplantatIon in SubjectS With MM - Mayo Clinic

   Has a known history of HIV (HIV 1/2 antibodies); Has known active Hepatitis B (e.g., Hepatitis B Surface Antigen [HBsAg] reactive) or Hepatitis C (e.g. ...

6. Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps - Mayo Clinic

   Antinuclear antibody (ANA) test result excludes overt autoimmune disease; note: test result may be reported in any of the following formats: =< 1:160, negative, ...

7. A Study to Evaluate Mutanome-directed Immunotherapy in Patients with Squamous Cell Carcinoma of the Head and Neck - Mayo Clinic

   Prior exposure to cancer immunotherapy including anti-cancer vaccines, any antibody ... antibodies. Other active malignancy requiring concurrent systemic ...

8. A Phase Ib/II Study of BYL719 and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma - Mayo Clinic

   ... antibody therapy is allowed regardless of the prior treatment settings. For Phase II, Arms 1 and 2, prior cetuximab or other EGFR-targeted antibody ...

9. Study of MK-8242 Alone and in Combination with Cytarabine in Participants with Acute Myelogenous Leukemia (P07649) - Mayo Clinic

   Clinically significant hepatitis at Screening, or hepatitis C antibody positive, hepatitis B surface antigen positive, or human immunodeficiency virus (HIV) ...

10. A Study of Markers in the Blood and/or Stored Kidney Biopsy Tissue in Patients with a History of Childhood Onset of Membranous Nephropathy - Mayo Clinic

    By collecting health information and laboratory samples, our goal is to learn more about membranous nephropathy. Due to discovery of additional antibodies and ...